Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dougald M Monroe

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Blood|December 7, 2007
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophiliaAnna G McDonald, Katie Yang, Harold R Roberts, et al.
Journal of Thrombosis and Haemostasis : JTH|March 9, 2024
Emicizumab promotes factor Xa generation on endothelial cellsAmmon M Fager, Patrick Ellsworth, Nigel S Key, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2019
A unique protein kinase C-dependent pathway for tissue factor downregulation in pericytesLaura J Sommerville, Kristen L Gorman, Stacey A Snyder, et al.
Seminars in Thrombosis and Hemostasis|March 3, 2021
The Art and Science of Building a Computational Model to Understand HemostasisKarin Leiderman, Suzanne S Sindi, Dougald M Monroe, et al.
Blood|July 11, 2006
Cutaneous wound healing is impaired in hemophilia BMaureane Hoffman, Anna Harger, Angela Lenkowski, et al.
Blood|July 2, 2002
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfacesJulie A Oliver, Dougald M Monroe, Frank C Church, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2010
Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cellsParam Vidwan, Alokkumar Pathak, Samar Sheth, et al.
Advances in Hematology|March 22, 2016
Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 PolymorphDougald M Monroe, Richard J Jenny, Kevin E Van Cott, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case seriesBrendan Kleiboer, Brenda Nielsen, Alica D Ma, et al.
British Journal of Haematology|December 15, 2005
High dose factor VIIa improves clot structure and stability in a model of haemophilia BAlisa S Wolberg, Geoffrey A Allen, Dougald M Monroe, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Blood|December 7, 2007
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophiliaAnna G McDonald, Katie Yang, Harold R Roberts, et al.
Journal of Thrombosis and Haemostasis : JTH|March 9, 2024
Emicizumab promotes factor Xa generation on endothelial cellsAmmon M Fager, Patrick Ellsworth, Nigel S Key, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2019
A unique protein kinase C-dependent pathway for tissue factor downregulation in pericytesLaura J Sommerville, Kristen L Gorman, Stacey A Snyder, et al.
Seminars in Thrombosis and Hemostasis|March 3, 2021
The Art and Science of Building a Computational Model to Understand HemostasisKarin Leiderman, Suzanne S Sindi, Dougald M Monroe, et al.
Blood|July 11, 2006
Cutaneous wound healing is impaired in hemophilia BMaureane Hoffman, Anna Harger, Angela Lenkowski, et al.
Blood|July 2, 2002
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfacesJulie A Oliver, Dougald M Monroe, Frank C Church, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2010
Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cellsParam Vidwan, Alokkumar Pathak, Samar Sheth, et al.
Advances in Hematology|March 22, 2016
Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 PolymorphDougald M Monroe, Richard J Jenny, Kevin E Van Cott, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 29, 2019
Excessive breakthrough bleeding in haemophilia B patients on factor IX-albumin fusion protein prophylactic therapy: A single centre case seriesBrendan Kleiboer, Brenda Nielsen, Alica D Ma, et al.
British Journal of Haematology|December 15, 2005
High dose factor VIIa improves clot structure and stability in a model of haemophilia BAlisa S Wolberg, Geoffrey A Allen, Dougald M Monroe, et al.
Pageof 8